India’s respiratory disease surge is creating massive demand for treatments, and pharma companies are moving fast to meet it.
Knee arthritis is a disease that plagues millions of Indians, often carrying an unspoken sentence, that of eventual knee replacement.
Fresh investment discussions between India and Switzerland could influence the future of India's leading life sciences hubs. The latest talks between India and Switzerland signal growing interest among Swiss companies in India's expanding life...
Alembic Pharma received a major regulatory boost after securing USFDA approval for its Tretinoin Cream USP, 0.025 percent. The development lifted investor sentiment, with Alembic Pharma shares gaining in trade following the announcement.
Wockhardt aims to derive 50% revenue from novel drugs in five years, led by antibiotics like Zaynich, as it strengthens its innovation-driven pharma strategy.
Bayer has launched Alka-Seltzer in India’s OTC digestive health segment, introducing an antacid with probiotic support to address acidity, gas and indigestion.
Indian pharma companies could soon find a new growth destination in Central Asia as Uzbekistan intensifies efforts to attract foreign investment in its pharmaceutical sector. The country has signaled its willingness to offer additional incentives...
India tightens drug safety norms and mandates pharmacovigilance systems as CDSCO directs pharma firms to strengthen ADR reporting, compliance checks, and post-market safety monitoring.
India's pharma exports to the US are expected to stay muted amid pricing pressure, policy uncertainty, and inventory correction in generics, with experts flagging structural shifts in demand and tighter procurement patterns.
For many couples, the experience of a dream baby comes with lots of queries and concerns. It is common knowledge that fertility treatment is an established procedure that is the same for each individual.
, CDSCO.jpg)
